Forbes contributors publish independent expert analyses and insights. Gary Drenik is a writer covering AI, analytics and innovation. Innovation is increasingly intertwined with advancements in ...

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

A new investment in R&D is a first step toward a research and development arm of the Department of Education, which could help advance technologies to aid student learning. Credit: Terrell Clark for ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

This activity was supported by a contract between the National Academy of Sciences and National Security Commission on Emerging Biotechnology via the U.S. Department of Defense (K15 HQ00342310017 ...

This year, the Department of Defense was authorized to spend $34 billion more on research and development than it was two years ago and only $18 billion more on procurement of new aircraft and ships.